Table 2
Demographic and baseline data of favourable and unfavourable outcome groups
| Favourable outcome, n=178 (%) | Unfavourable outcome, n=42 (%) | P value | |
| Male | 99 (55.6) | 27 (64.3) | 0.307 |
Age (
, years) | 56.2±8.1 | 65.3±8.8 | 0.000 |
| History of hyperlipidaemia | 53 (29.8) | 13 (31.0) | 0.881 |
| History of diabetes | 38 (19.3) | 15 (30.6) | 0.084 |
| History of coronary heart disease | 7 (3.9) | 2 (4.8) | 0.682* |
| History of atrial fibrillation | 0 (0) | 1 (2.4) | 0.191* |
| History of stroke | 3 (1.7) | 5 (11.9) | 0.007* |
| Smoking | 90 (50.6) | 26 (61.9) | 0.185 |
| Alcohol abuse | 62 (34.8) | 19 (46.3) | 0.169 |
| Hypotension | 130 (73.0) | 29 (69.0) | 0.604 |
| Warfarin treatment | 8 (4.5) | 4 (9.5) | 0.250* |
SBP (
, mm Hg) | 162.9±22.8 | 164.5±24.2 | 0.535 |
DBP (
, mm Hg) | 103.7±9.1 | 104.9±9.3 | 0.674 |
| ICH location, n (%) | |||
| Basal ganglia | 95 (53.4) | 21 (50.0) | 0.694 |
| Thalamus | 68 (38.2) | 19 (45.2) | 0.402 |
| Lobar | 15 (8.4) | 2 (4.8) | 0.538* |
| Baseline ICH volume, median (IQR), mL | 30 (21–39) | 33 (22–38) | 0.035 |
| ICH score, median (IQR) | 2 (0–3) | 2 (1–3) | 0.316 |
| IVH presence | 26 (14.6) | 13 (31.0) | 0.013 |
| Midline shift | 145 (81.5) | 37 (88.1) | 0.306 |
| Admission GCS, median (IQR) | 11 (9–14) | 10 (9–13) | 0.038 |
Haemoglobin (
, g/L) | 108.7±13.4 | 105.3±13.2 | 0.332 |
| Blood glucose, median (IQR) | 7.4 (6.2–8.7) | 8.9 (6.8–11.2) | 0.027 |
| INR, median (IQR) | 1.1 (0.7–1.3) | 1.2 (0.8–1.4) | 0.152 |
Onset to the first CT time (min, 
) | 182.7±53.3 | 181.8±53.4 | 0.627 |
Onset to admission time (min, 
) | 165.18±51.4 | 165.7±50.5 | 0.884 |
| Treatment plan, n (%) | 0.000 | ||
| Stereotactic aspiration | 126 (88.7) | 16 (11.3) | |
| Conservative treatment | 52 (70.8) | 26 (38.1) |
*Fisher’s exact test.
DBP, diastolic blood pressure, 1 mm Hg=0.133 kPa; GCS, Glasgow Coma Scale; ICH, intracerebral haemorrhage; INR, International normalised ratio; IVH, intraventricular haemorrhage; SBP, systolic blood pressure.